Neurology in Murrells Inlet, SC
3 verified neurology doctors in Murrells Inlet.
Neurologists diagnose and treat disorders of the brain, spinal cord, and nervous system, such as migraines, epilepsy, and stroke.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the South Carolina Board of Medical Examiners
Dr. Scott Callaghan, DO
Neurology
CMS Open Payments· $100.82 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$100.82
Total received
5
Transactions
4
Paying companies
Top paying companies
Among the 22,669 neurology doctors we've analyzed, about 51% received any industry payment (median $640 among those who did). This doctor's total ranks around the 59th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US neurology doctors.
Payments to Scott Callaghan do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Michael Mccaffrey, MD
Neurology
CMS Open Payments· $443.69 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$443.69
Total received
37
Transactions
6
Paying companies
Top paying companies
Among the 22,669 neurology doctors we've analyzed, about 51% received any industry payment (median $640 among those who did). This doctor's total ranks around the 72th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US neurology doctors.
Payments to Michael Mccaffrey do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Mckenzye Dehart Mccoyle, DO
Neurology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.